The first research results to emerge from the MURDOCK Study were presented last week at an international conference in San Francisco, giving hope to people who suffer from hepatitis C.

Duke University scientists and physicians working for the study, which is an acronym devised to honor N.C. Research Campus founder David Murdock, have discovered an important genetic clue that may help unlock the mystery of hepatitis C infection.

"I’m incredibly excited about it," said Dr. John McHutchison, a lead investigator for the study and associate director of the Duke Clinical Research Institute. McHutchison’s team has identified a set of proteins that may be able to predict who will most likely respond to standard therapy for hepatitis C infection.

For details, see